Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Speaking from the CAR-T Cell Therapy and the ICU 2019 meeting in London, UK, which was organized by EuroCARTForce, Sigurdur Sigurdsson, of the Icelandic Heart Association, Kopavogur, Iceland, discusses how best to approach the treatment of CAR-T patients.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.